QUOTE AND NEWS
The Globe and Mail  Nov 9  Comment 
Deferred revenue payments from partnership help Cardiome trim loss
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardiome+Pharma+%28CRME%29+Reports+a+Q1+Loss/5087426.html for the full story.
The Globe and Mail  Oct 14  Comment 
To pay $4.25 (U.S.) per share, the minimum price of a previously announced range
StreetInsider.com  Sep 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Cardiome+Pharma+%28CRME%29+Extends+%22Dutch+Auction%22+Tender+Offer/4972252.html for the full story.
StreetInsider.com  Sep 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cardiome+Pharma+%28CRME%29+Commences+%2427.5M+Tender+Offer/4914751.html for the full story.
Motley Fool  Aug 31  Comment 
The drugmaker faces an FDA advisory-panel showdown.
Motley Fool  Aug 26  Comment 
The smart money has flocked to these stocks.
StreetInsider.com  Aug 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/Cardiome+Pharma+%28CRME%29+Announces+Tender+Offer+To+Purchase+Up+To+US%2427.5+Million+Of+Its+Common+Shares/4900794.html for the full story.
Motley Fool  Aug 24  Comment 
Market-trouncing returns could be written in these five stars.
newratings.com  Aug 12  Comment 
NEW YORK, August 12 (newratings.com) - Analysts at RBC Capital Markets reiterate their "sector perform" rating on Cardiome Pharma Corporation (ticker: CRME). The target price has been reduced from $11.50 to $9. [more]
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
CRME AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki